本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.2183
-0.0517-19.15%
盘前0.25090.0326+14.93%09:13 EST
成交量:4,290.97万
成交额:1,145.96万
市值:3,150.08万
市盈率:-0.46
高:0.3128
开:0.2944
低:0.2182
收:0.2700
52周最高:10.48
52周最低:0.2182
股本:1.44亿
流通股本:1.20亿
量比:4.14
换手率:35.69%
股息:- -
股息率:- -
每股收益(TTM):-0.4752
每股收益(LYR):-0.7570
净资产收益率:-150.82%
总资产收益率:-84.32%
市净率:1.81
市盈率(LYR):-0.29

数据加载中...

2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/24

SEC问询函

Form CORRESP - Correspondence
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report